BiON plc Logo

BiON plc

BION.L

(1.8)
Stock Price

0,15 GBp

-105.56% ROA

2034.9% ROE

-0.03x PER

Market Cap.

6.808.609,16 GBp

-105.71% DER

0% Yield

-117.26% NPM

BiON plc Stock Analysis

BiON plc Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

BiON plc Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (2034.9%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (-0.06x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a minimal amount of debt (-106%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

5 ROA

The stock's ROA (-105.56%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-3) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

BiON plc Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

BiON plc Technical Stock Analysis
# Analysis Recommendation

BiON plc Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

BiON plc Revenue
Year Revenue Growth
2015 0
2016 12.537.612 100%
2017 8.011.245 -56.5%
2019 24.061.000 66.7%
2020 103.673.000 76.79%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

BiON plc Research and Development Expenses
Year Research and Development Expenses Growth
2015 0
2016 0 0%
2017 0 0%
2019 0 0%
2020 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

BiON plc General and Administrative Expenses
Year General and Administrative Expenses Growth
2015 0
2016 943.461 100%
2017 2.443.444 61.39%
2019 8.839.000 72.36%
2020 132.199.000 93.31%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

BiON plc EBITDA
Year EBITDA Growth
2015 0
2016 2.247.001 100%
2017 -144.699 1652.89%
2019 5.586.000 102.59%
2020 -120.406.000 104.64%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

BiON plc Gross Profit
Year Gross Profit Growth
2015 0
2016 3.174.086 100%
2017 2.061.998 -53.93%
2019 3.052.000 32.44%
2020 6.265.000 51.28%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

BiON plc Net Profit
Year Net Profit Growth
2015 0
2016 1.847.658 100%
2017 -476.851 487.47%
2019 -65.000 -633.62%
2020 -121.565.000 99.95%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

BiON plc Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2015 0
2016 0 0%
2017 0 0%
2019 0 0%
2020 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

BiON plc Free Cashflow
Year Free Cashflow Growth
2015 441.782
2016 -6.489.784 106.81%
2017 -2.089.383 -210.61%
2019 -1.263.250 -65.4%
2020 -49.435.000 97.44%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

BiON plc Operating Cashflow
Year Operating Cashflow Growth
2015 2.101.175
2016 -3.650.096 157.56%
2017 -334.450 -991.38%
2019 95.250 451.13%
2020 -12.905.000 100.74%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

BiON plc Capital Expenditure
Year Capital Expenditure Growth
2015 1.659.393
2016 2.839.688 41.56%
2017 1.754.933 -61.81%
2019 1.358.500 -29.18%
2020 36.530.000 96.28%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

BiON plc Equity
Year Equity Growth
2016 7.724.657
2017 8.355.765 7.55%
2019 50.056.000 83.31%
2020 -61.693.000 181.14%
2022 190.000 32570%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

BiON plc Assets
Year Assets Growth
2016 16.352.767
2017 19.695.253 16.97%
2019 127.515.000 84.55%
2020 115.883.000 -10.04%
2022 499.000 -23123.05%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

BiON plc Liabilities
Year Liabilities Growth
2016 8.628.110
2017 11.339.487 23.91%
2019 77.459.000 85.36%
2020 177.576.000 56.38%
2022 309.000 -57367.96%

BiON plc Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.24
Net Income per Share
-0.29
Price to Earning Ratio
-0.03x
Price To Sales Ratio
0.07x
POCF Ratio
-0.29
PFCF Ratio
-0.14
Price to Book Ratio
-0.06
EV to Sales
0.67
EV Over EBITDA
-0.58
EV to Operating CashFlow
-5.42
EV to FreeCashFlow
-1.41
Earnings Yield
-32.18
FreeCashFlow Yield
-7.26
Market Cap
0,01 Bil.
Enterprise Value
0,07 Bil.
Graham Number
0.97
Graham NetNet
-0.41

Income Statement Metrics

Net Income per Share
-0.29
Income Quality
0.11
ROE
20.35
Return On Assets
-1.05
Return On Capital Employed
-40.22
Net Income per EBT
1.01
EBT Per Ebit
0.96
Ebit per Revenue
-1.21
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
1.28
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.06
Operating Profit Margin
-1.21
Pretax Profit Margin
-1.16
Net Profit Margin
-1.17

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.03
Free CashFlow per Share
-0.12
Capex to Operating CashFlow
2.83
Capex to Revenue
-0.35
Capex to Depreciation
-13.19
Return on Invested Capital
-13.21
Return on Tangible Assets
-1.06
Days Sales Outstanding
0
Days Payables Outstanding
333.66
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
1.09
Inventory Turnover
0
Capex per Share
-0.09

Balance Sheet

Cash per Share
0,01
Book Value per Share
-0,15
Tangible Book Value per Share
-0.15
Shareholders Equity per Share
-0.15
Interest Debt per Share
0.16
Debt to Equity
-1.06
Debt to Assets
0.56
Net Debt to EBITDA
-0.52
Current Ratio
0.19
Tangible Asset Value
-0,06 Bil.
Net Current Asset Value
-0,16 Bil.
Invested Capital
-1.06
Working Capital
-0,09 Bil.
Intangibles to Total Assets
0.01
Average Receivables
0,00 Bil.
Average Payables
0,06 Bil.
Average Inventory
0
Debt to Market Cap
9.6

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

BiON plc Dividends
Year Dividends Growth

BiON plc Profile

About BiON plc

BiON plc does not have significant operations. Previously, it was engaged in the research and development activities; provision of professional engineering consultancy and process design services in the areas of industrial biotechnology, pollution control, and renewable energy; engineering, procurement, and construction of waste water treatment plants/systems; and development, commercialization, operation, and maintenance of biogas power plants. The company was formerly known as Green & Smart Holdings plc and changed its name to BiON plc in May 2020. BiON plc is headquartered in Kuala Lumpur, Malaysia.

CEO
Mr. Wan Azmi Wan Ahmad
Employee
20
Address
D2-3-1 Solaris Dutamas 1
Kuala Lumpur, 50480

BiON plc Executives & BODs

BiON plc Executives & BODs
# Name Age
1 Mr. Thannimalai Renganathan
Chief Technical Officer
70
2 Mr. Wan Azmi Wan Ahmad
Acting Chief Operations Officer
70

BiON plc Competitors